AbbVie Inc. (ABBV)

Which Pharma Stock Looks More Attractive: Sanofi or AbbVie?

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

Blockbuster Drugs Come and Go. These 5 Pharma Dividend Stocks Keep Paying

A Look at AbbVie Inc (ABBV) After 2.4% Decline -- GF Value $222.10 vs Price $274.36

AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?

5 High-Yield Dividend Stocks That Could Turn October's Market Weakness Into Income

Netflix, DocuSign And A Health Care Stock On CNBC's ‘Final Trades'

AbbVie (NYSE:ABBV) Reaches New 52-Week High – Here’s Why

AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?

AbbVie (ABBV) Rises As Market Takes a Dip: Key Facts

Biotech's Rebound Reality: Surging M&A Deals Meet Deep Retail Skepticism

Will Skyrizi & Rinvoq Drive AbbVie's Top-Line Growth in Q3?

Prediction: AbbVie's Next Billion-Dollar Opportunity Is Taking Shape

Which Pharmaceuticals ETF Is the Better Buy: iShares’ IHE or Invesco’s PJP?

Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE?

New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease

5 Dividend Stocks for Retirees Who Want More Than Just a Big Yield

AbbVie's Dividend Yield Is at Its Lowest Level Since 2018. Here's Why the Stock Is Still a Great Pick for Income Investors Anyway.

A Stock Market Crash Is Coming By the End of 2027, According to Some Economists. Here Are 2 Stocks to Buy Before That Happens

Treasury Bills or Dividend Stocks? The Retirement Income Math May Surprise You